Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by biren1

V.INT

RE: honest question

No news has been officially sent out from the company as of yet advising of...

July 13, 2012

V.INT

RE: Ask

that's what leading me to believe that additional shares are hitting the...

July 13, 2012

V.INT

tried calling IR, but just got the machine

Hey guys, i just tried calling IR again but just got lynn's answering...

July 13, 2012

V.INT

RE: Popularity & User numbers

this is exactly the reason i continue to hold sizzlin. Nothing has changed...

July 13, 2012

V.INT

RE: Blood in the water...

how i look at it is that some of the initial selling was definetly based on...

July 13, 2012

V.INT

RE: RE: RE: RE: RE: Kensin

have bids myself at 25 cents and lower, there has to be a correction at some...

July 13, 2012

V.INT

RE: RE: RE: RE: RE: nothing changed

i tend to agree The one thing i will agree with the bashers on is that the...

July 12, 2012

V.INT

RE: RE: RE: nothing changed

i would agree woolie that a 40 million share dilution at 25 cents would...

July 12, 2012

V.INT

RE: RE: nothing changed

i know you might disagree with the posts of other people here, but in all...

July 12, 2012

V.INT

End game strategy is the key

i think the key to int everyone has to remember is what if your end game...

July 12, 2012

V.INT

RE: RE: RE: RE: Patents? drdish..

i think might link be broken if you just click on it. You might have to...

July 12, 2012

V.INT

RE: RE: RE: Patents? drdish..

Found this link from the US patent website for a patent application in...

July 12, 2012

V.INT

RE: Maxim conversion price

there is definetly speculation in regards to the private placement being the...

July 12, 2012

V.INT

RE: Muddy Waters Today

certainly a nice base building between 28-31 cents based on the number of...

July 12, 2012

V.INT

RE: RE: RE: Incredible....

I think unfortunatly that the delays are leading to people losing paitence...

July 12, 2012

V.INT

RE: Incredible....

I agree that it looks oversold. The big problem right now is that the overall...

July 12, 2012

T.CMK

RE: RE: RE: The drop continues(reply)

definetly worth a gamble as a long term play with all the coal they have in...

July 12, 2012

V.INT

RE: Super longs are shocked at the turn of

It really is a 2 sided coin for me as to how i look at the situation. On the...

July 12, 2012

V.INT

RE: RE: paitence looks to be thin

The beauty of having a diversified portfolio allows an investor like me to...

July 11, 2012

V.INT

paitence looks to be thin

Well the stock price closed today at 32 cents after being as low as 29 cents....

July 11, 2012

Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next

Featured Company

MindBio Therapeutics Corp.

MindBio Therapeutics Corp. C.MBIO

MindBio Therapeutics Corp is a pioneering clinical stage biotechnology company that specializes in developing psychedelic ... view more »